A Study on BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia from Western India
Background: BCR-ABL kinase domain(KD) mutations accounts for 60-80% of Imatinib resistance in chronic myeloid leukemia (CML) – chronic phase (CP). Patients with CML who are receiving imatinib treatment, a mutation analysis is required to find out the resistance of imatinib as per European Leukemia N...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
West Asia Organization for Cancer Prevention
2021-10-01
|
Series: | Asian Pacific Journal of Cancer Biology |
Subjects: | |
Online Access: | http://www.waocp.com/journal/index.php/apjcb/article/view/740 |